Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1) -: Marked insensitivity toward different regulatory axes

被引:118
作者
Ohyama, Y
Meaney, S
Heverin, M
Ekström, L
Brafman, A
Shafir, M
Andersson, U
Olin, M
Eggertsen, G
Diczfalusy, U
Feinstein, E
Björkhem, I
机构
[1] Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, S-14186 Huddinge, Sweden
[2] Karolinska Univ Hosp, Dept Lab Med, Div Clin Pharmacol, S-14186 Huddinge, Sweden
[3] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan
[4] Quark Biotech, Fremont, CA 94555 USA
关键词
D O I
10.1074/jbc.M505179200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian CNS contains a disproportionally large and remarkably stable pool of cholesterol. Despite an efficient recycling there is some requirement for elimination of brain cholesterol. Conversion of cholesterol into 24S-hydroxycholesterol by the cholesterol 24-hydroxylase (CYP46A1) is the quantitatively most important mechanism. Based on the protein expression and plasma levels of 24S-hydroxycholesterol, CYP46A1 activity appears to be highly stable in adults. Here we have made a structural and functional characterization of the promoter of the human CYP46A1 gene. No canonical TATA or CAAT boxes were found in the promoter region. Moreover this region had a high GC content, a feature often found in genes considered to have a largely housekeeping function. A broad spectrum of regulatory axes using a variety of promoter constructs did not result in a significant transcriptional regulation. Oxidative stress caused a significant increase in transcriptional activity. The possibility of a substrate-dependent transcriptional regulation was explored in vivo in a sterol-deficient mouse model (Dhcr24 null) in which almost all cholesterol had been replaced with desmosterol, which is not a substrate for CYP46A1. Compared with heterozygous littermates there was no statistically significant difference in the mRNA levels of Cyp46a1. During the first 2 weeks of life in the wild-type mouse, however, a significant increase of Cyp46a1 mRNA levels was found, in parallel with an increase in 24S-hydroxycholesterol level and a reduction of cholesterol synthesis. The failure to demonstrate a significant transcriptional regulation under most conditions is discussed in relation to the turnover of brain and neuronal cholesterol.
引用
收藏
页码:3810 / 3820
页数:11
相关论文
共 54 条
[1]   Turnover of myelin lipids in aging brain [J].
Ando, S ;
Tanaka, Y ;
Toyoda, Y ;
Kon, K .
NEUROCHEMICAL RESEARCH, 2003, 28 (01) :5-13
[2]   The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset [J].
Beyer, K ;
Lao, JI ;
Gómez, M ;
Riutort, N ;
Latorre, P ;
Mate, JL ;
Ariza, A .
NEUROSCIENCE LETTERS, 2002, 326 (03) :187-190
[3]   Brain cholesterol:: Long secret life behind a barrier [J].
Björkhem, I ;
Meaney, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :806-815
[4]   From brain to bile -: Evidence that conjugation and ω-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans [J].
Björkhem, I ;
Andersson, U ;
Ellis, E ;
Alvelius, G ;
Ellegård, L ;
Diczfalusy, U ;
Sjövall, J ;
Einarsson, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) :37004-37010
[5]  
Björkhem I, 1998, J LIPID RES, V39, P1594
[6]   Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro [J].
Bjorkhem, I ;
Lutjohann, D ;
Breuer, O ;
Sakinis, A ;
Wennmalm, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30178-30184
[7]   On the turnover of brain cholesterol in patients with Alzheimer's disease.: Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells [J].
Bogdanovica, N ;
Bretillon, L ;
Lund, EG ;
Diczfalusy, U ;
Lannfelt, L ;
Winblad, B ;
Russell, DW ;
Björkhem, I .
NEUROSCIENCE LETTERS, 2001, 314 (1-2) :45-48
[8]   Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators [J].
Borroni, B ;
Archetti, S ;
Agosti, C ;
Akkawi, N ;
Brambilla, C ;
Caimi, L ;
Caltagirone, C ;
Di Luca, M ;
Padovani, A .
NEUROBIOLOGY OF AGING, 2004, 25 (06) :747-751
[9]  
Bretillon L, 2000, J LIPID RES, V41, P840
[10]   Differential expression of cholesterol hydroxylases in Alzheimer's disease [J].
Brown, J ;
Theisler, C ;
Silberman, S ;
Magnuson, D ;
Gottardi-Littell, N ;
Lee, JM ;
Yager, D ;
Crowley, J ;
Sambamurti, K ;
Rahman, MM ;
Reiss, AB ;
Eckman, CB ;
Wolozin, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) :34674-34681